Health In Tech, Inc. (NASDAQ:HIT – Get Free Report) Director Timothy Hayes sold 12,000 shares of the stock in a transaction on Friday, September 11th. The shares were sold at an average price of $0.91, for a total value of $10,920.00. Following the completion of the transaction, the director owned 120,780 shares in the company, valued at $109,909.80. The trade was a 9.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.
Timothy Hayes also recently made the following trade(s):
- On Wednesday, September 9th, Timothy Hayes sold 5,730 shares of Health In Tech stock. The stock was sold at an average price of $0.93, for a total value of $5,328.90.
Health In Tech Price Performance
Shares of HIT stock traded down $0.03 on Friday, reaching $0.91. 122,541 shares of the stock were exchanged, compared to its average volume of 217,514. Health In Tech, Inc. has a one year low of $0.85 and a one year high of $4.02. The stock has a market cap of $59.36 million, a PE ratio of -12.94 and a beta of 2.72. The stock has a 50 day moving average price of $1.04 and a 200 day moving average price of $1.23.
Hedge Funds Weigh In On Health In Tech
Several institutional investors have recently modified their holdings of HIT. Raymond James Financial Inc. bought a new stake in Health In Tech during the 3rd quarter worth approximately $45,000. Squarepoint Ops LLC acquired a new position in shares of Health In Tech in the third quarter valued at approximately $46,000. Millennium Management LLC bought a new stake in shares of Health In Tech during the third quarter worth $85,000. Jane Street Group LLC increased its position in shares of Health In Tech by 307.9% during the fourth quarter. Jane Street Group LLC now owns 50,648 shares of the company’s stock worth $81,000 after acquiring an additional 38,230 shares in the last quarter. Finally, State Street Corp raised its holdings in shares of Health In Tech by 195.3% during the fourth quarter. State Street Corp now owns 62,900 shares of the company’s stock worth $100,000 after acquiring an additional 41,600 shares during the period.
Wall Street Analyst Weigh In
HIT has been the topic of several recent research reports. Maxim Group reduced their target price on shares of Health In Tech from $4.00 to $3.00 and set a “buy” rating on the stock in a research note on Friday, August 14th. Weiss Ratings reissued a “sell (d)” rating on shares of Health In Tech in a research note on Tuesday, June 30th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Health In Tech presently has an average rating of “Moderate Buy” and an average price target of $3.50.
View Our Latest Stock Analysis on HIT
About Health In Tech
Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.
See Also
- Five stocks we like better than Health In Tech
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Health In Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health In Tech and related companies with MarketBeat.com's FREE daily email newsletter.
